# Circulating Tumor Cell Counts Are Prognostic of Overall Survival in SWOG S0421: A Phase III Trial of Docetaxel With or Without Atrasentan for Metastatic Castration-Resistant Prostate Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/circulating-tumor-cell-counts-are-prognostic-of-overall-survival-in-swog-s0421-a/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Amir Goldkorn,Benjamin Ely,David I. Quinn,Catherine M. Tangen,Louis M. Fink,Tong Xu,Przemyslaw Twardowski,Peter J. Van Veldhuizen,Neeraj Agarwal,Michael A. Carducci,J. Paul Monk,Ram H. Datar,Mark Garzotto,Philip C. Mack,Primo N. Lara,Celestia S. Higano,Maha Hussain,Ian M. Thompson,Richard J. Côté,Nicholas J. Vogelzang |
| Citations | 334 |
| DOI | 10.1200/jco.2013.51.7417 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://www.ncbi.nlm.nih.gov/pmc/articles/3970171 |
| OpenAlex ID | https://openalex.org/W2103793201 |
| PMID | 24616308 |
| Type | article |
| Year | 2014 |

## Paper authors

- [Michael A. Carducci](https://scholariq.org/researchers/michael-a-carducci/)
- [Neeraj Agarwal](https://scholariq.org/researchers/neeraj-agarwal/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)

## Paper topics

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Cancer Cells and Metastasis](https://scholariq.org/topics/cancer-cells-and-metastasis/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.